Cornelis Vlaar to Drug Design
This is a "connection" page, showing publications Cornelis Vlaar has written about Drug Design.
Connection Strength
1.079
-
Vlaar CP, Castillo-Pichardo L, Medina JI, Marrero-Serra CM, V?lez E, Ramos Z, Hern?ndez E. Design, synthesis and biological evaluation of new carbazole derivatives as anti-cancer and anti-migratory agents. Bioorg Med Chem. 2018 02 15; 26(4):884-890.
Score: 0.487
-
Dharmawardhane S, Hernandez E, Vlaar C. Development of EHop-016: a small molecule inhibitor of Rac. Enzymes. 2013; 33 Pt A:117-46.
Score: 0.358
-
Parapini S, D'Alessandro S, Travaglione S, Paone S, Madera Cuevas IM, Dipol T, Zongo DWR, Figueroa V?zquez AM, Morsilli O, Fabbri A, Vlaar CP, Olivieri A. Design, synthesis and biological evaluation of Rac1-targeting carbazole-pyrimidines as host-directed antimalarials. Eur J Med Chem. 2026 Apr 15; 308:118690.
Score: 0.213
-
Montalvo-Ortiz BL, Castillo-Pichardo L, Hern?ndez E, Humphries-Bickley T, De la Mota-Peynado A, Cubano LA, Vlaar CP, Dharmawardhane S. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. J Biol Chem. 2012 Apr 13; 287(16):13228-38.
Score: 0.020